Prospective Clinical Assessment Study in Children With Hypochondroplasia

Clinical trial NCT06410976 · RECRUITING

Trial details

NCT number: NCT06410976
Sponsor: QED Therapeutics, a BridgeBio company
Status: RECRUITING
Study type: OBSERVATIONAL

Hypochondroplasia

Start date: 2024-06-05
Primary completion: 2026-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.